Metraipolis › archive › dc_15e950aba349
Denecimig (Mim8) prophylaxis over 52 weeks in adolescents and adults with hemophilia A: FRONTIER2 extension study — Europe PMC PMID:42824064
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42824064
- DOI
- 10.1016/j.rpth.2026.106915
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-08T13:26:53.690Z
- SHA-256 of the archived text
691cb432fcd94bc9d6092435673269be71d46fdc440dc9d1153bd7cd7c8c30ee- Stable URL of this page
https://metraipolis.com/documento/dc_15e950aba349
How to cite
Denecimig (Mim8) prophylaxis over 52 weeks in adolescents and adults with hemophilia A: FRONTIER2 extension study — Europe PMC PMID:42824064 — Europe PMC (en), https://europepmc.org/article/MED/42824064 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_15e950aba349 (Metraipolis archive dc_15e950aba349, sha256 691cb432fcd94bc9d6092435673269be71d46fdc440dc9d1153bd7cd7c8c30ee)
BibTeX
@misc{dc15e950aba349,
title = {Denecimig (Mim8) prophylaxis over 52 weeks in adolescents and adults with hemophilia A: FRONTIER2 extension study — Europe PMC PMID:42824064},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42824064},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_15e950aba349; sha256 691cb432fcd94bc9d6092435673269be71d46fdc440dc9d1153bd7cd7c8c30ee},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42824064. Agents can read the archived copy with the MCP tool read_document.